AVPR1A
MOLECULAR TARGETarginine vasopressin receptor 1A
AVPR1A (arginine vasopressin receptor 1A) is targeted by 11 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting AVPR1A
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | Arginine Vasopressin | 3.66 | 38 |
| 2 | Oxytocin | 3.18 | 23 |
| 3 | Deamino Arginine Vasopressin | 1.61 | 4 |
| 4 | Ornipressin | 1.61 | 4 |
| 5 | Amdinocillin | 0.69 | 1 |
| 6 | Aripiprazole | 0.69 | 1 |
| 7 | Astemizole Antihistamine drug now withdrawn from | 0.69 | 1 |
| 8 | Calcimycin | 0.69 | 1 |
| 9 | Daunorubicin | 0.69 | 1 |
| 10 | Lypressin | 0.69 | 1 |
| 11 | Ritonavir | 0.69 | 1 |
About AVPR1A as a Drug Target
AVPR1A (arginine vasopressin receptor 1A) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 11 compounds with documented AVPR1A interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
AVPR1A inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.